Using a newly developed multicomponent chemistry strategy in combination with structure based drug design, a new class of HIV-1 protease inhibitors has been obtained.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2004.04.026 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!